Process for Preparing Pure Amorphous Rosuvastatin Calcuim
AssigneeLek D.D
InventorsZendko Casar, Marko Zlicar
Life of this patent
Estimating the term…
Loading patent…
AssigneeLek D.D
InventorsZendko Casar, Marko Zlicar
Estimating the term…
A new process for preparing pure amorphous rosuvastatin calcium, substantially free of impurities, is disclosed. A process comprising hydrolysing a C1 to C5 alkyl ester of rosuvastatin, preferably methyl rosuvastatin or tert-butyl rosuvastatin, with a base, e.g. sodium hydroxide, in the presence of an aprotic solvent, preferably tetrahydrofuran and N,N-dimethyl acetamide, or in the presence of a mixture of an aprotic solvent and water, to obtain a solution of rosuvastatin salt, which may be converted to another rosuvastatin salt using another cation, e.g. with calcium cation to obtain rosuvastatin calcium. Rosuvastatin amine salts may be obtained as well. In another preferred aspect of the invention rosuvastatin free acid may be converted to various rosuvastatin salts, e.g. to rosuvastain calcium, rosuvastatin sodium or various rosuvastatin amine salts, including rosuvastatin solvates, e.g. rosuvastatin calcium hydrate. Rosuvastatin calcium is useful in the treatment of hyperlipidemia, hypercholesterolemia and atherosclerosis.
A process for producing pure amorphous rosuvastatin calcium which comprises:
A process for producing amorphous rosuvastatin calcium, which includes the steps of:
A process for producing rosuvastatin free acid, which includes the steps of:
A process for producing rosuvastatin salts, wherein isolated rosuvastatin free acid is contacting with cation source in an organic solvent.
Substantially anhydrous rosuvastatin calcium having water content less than 0.1% by weight.
Dependencies are inferred from the claim text.